MC2R Gene Glucocorticoid Deficiency Type 1 Genetic Test
Test Name: MC2R Gene Glucocorticoid Deficiency Type 1 Genetic Test
Components: DNA Labs UAE
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MC2R Gene Glucocorticoid Deficiency Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glucocorticoid Deficiency Type 1.
Test Details
The MC2R gene is responsible for encoding the melanocortin 2 receptor, which plays a crucial role in the production and regulation of cortisol, a hormone involved in stress response and metabolism. Glucocorticoid Deficiency Type 1 (GC1) is a rare genetic disorder characterized by impaired cortisol production due to mutations in the MC2R gene.
NGS (Next-Generation Sequencing) is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the MC2R gene, in a high-throughput manner. This technique can identify mutations or variants in the MC2R gene that may be associated with Glucocorticoid Deficiency Type 1.
The NGS genetic test for MC2R gene Glucocorticoid Deficiency Type 1 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variants in the MC2R gene.
The results of the test can help in confirming a diagnosis of Glucocorticoid Deficiency Type 1 and may also provide information about the specific genetic variant causing the condition. Genetic testing for MC2R gene Glucocorticoid Deficiency Type 1 can be useful in guiding treatment decisions, providing genetic counseling, and identifying at-risk family members who may benefit from early intervention or screening.
However, it is important to note that genetic testing should always be interpreted in the context of a comprehensive clinical evaluation, and the results should be discussed with a healthcare professional or genetic counselor.
| Test Name | MC2R Gene Glucocorticoid deficiency type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MC2R Gene Glucocorticoid deficiency type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glucocorticoid deficiency type 1 |
| Test Details |
The MC2R gene is responsible for encoding the melanocortin 2 receptor, which plays a crucial role in the production and regulation of cortisol, a hormone involved in stress response and metabolism. Glucocorticoid deficiency type 1 (GC1) is a rare genetic disorder characterized by impaired cortisol production due to mutations in the MC2R gene. NGS (Next-Generation Sequencing) is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the MC2R gene, in a high-throughput manner. This technique can identify mutations or variants in the MC2R gene that may be associated with glucocorticoid deficiency type 1. The NGS genetic test for MC2R gene glucocorticoid deficiency type 1 involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variants in the MC2R gene. The results of the test can help in confirming a diagnosis of glucocorticoid deficiency type 1 and may also provide information about the specific genetic variant causing the condition. Genetic testing for MC2R gene glucocorticoid deficiency type 1 can be useful in guiding treatment decisions, providing genetic counseling, and identifying at-risk family members who may benefit from early intervention or screening. However, it is important to note that genetic testing should always be interpreted in the context of a comprehensive clinical evaluation, and the results should be discussed with a healthcare professional or genetic counselor. |
